JP2007506426A5 - - Google Patents

Download PDF

Info

Publication number
JP2007506426A5
JP2007506426A5 JP2006527773A JP2006527773A JP2007506426A5 JP 2007506426 A5 JP2007506426 A5 JP 2007506426A5 JP 2006527773 A JP2006527773 A JP 2006527773A JP 2006527773 A JP2006527773 A JP 2006527773A JP 2007506426 A5 JP2007506426 A5 JP 2007506426A5
Authority
JP
Japan
Prior art keywords
brc
polypeptide
breast cancer
expression level
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006527773A
Other languages
English (en)
Japanese (ja)
Other versions
JP4620670B2 (ja
JP2007506426A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2004/014438 external-priority patent/WO2005028676A2/en
Publication of JP2007506426A publication Critical patent/JP2007506426A/ja
Publication of JP2007506426A5 publication Critical patent/JP2007506426A5/ja
Application granted granted Critical
Publication of JP4620670B2 publication Critical patent/JP4620670B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006527773A 2003-09-24 2004-09-24 乳癌を診断する方法 Expired - Fee Related JP4620670B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50557103P 2003-09-24 2003-09-24
PCT/JP2004/014438 WO2005028676A2 (en) 2003-09-24 2004-09-24 Method of diagnosing breast cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007237927A Division JP2008092949A (ja) 2003-09-24 2007-09-13 乳癌を診断する方法

Publications (3)

Publication Number Publication Date
JP2007506426A JP2007506426A (ja) 2007-03-22
JP2007506426A5 true JP2007506426A5 (enExample) 2007-11-08
JP4620670B2 JP4620670B2 (ja) 2011-01-26

Family

ID=34375580

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006527766A Expired - Fee Related JP4579246B2 (ja) 2003-09-24 2004-08-10 乳癌を診断する方法
JP2006527773A Expired - Fee Related JP4620670B2 (ja) 2003-09-24 2004-09-24 乳癌を診断する方法
JP2007237927A Withdrawn JP2008092949A (ja) 2003-09-24 2007-09-13 乳癌を診断する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006527766A Expired - Fee Related JP4579246B2 (ja) 2003-09-24 2004-08-10 乳癌を診断する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007237927A Withdrawn JP2008092949A (ja) 2003-09-24 2007-09-13 乳癌を診断する方法

Country Status (9)

Country Link
US (3) US7531300B2 (enExample)
EP (2) EP1668354A2 (enExample)
JP (3) JP4579246B2 (enExample)
CN (2) CN1898563B (enExample)
AT (1) ATE508202T1 (enExample)
DE (1) DE602004032556D1 (enExample)
ES (1) ES2365732T3 (enExample)
TW (2) TW200512298A (enExample)
WO (2) WO2005029067A2 (enExample)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005054510A2 (en) * 2003-12-05 2005-06-16 Erasmus Mc Predicting response and outcome of metastatic breast cancer anti-estrogen therapy
FR2875512B1 (fr) * 2004-09-17 2011-02-04 Diagnogene S A Biopuce de diagnostic du caractere metastatique ou localise d'une tumeur mammaire, procede et kit d'utilisation
EP1854473A1 (en) * 2005-03-03 2007-11-14 Takeda Pharmaceutical Company Limited Preventive/therapeutic agent for cancer
ATE473761T1 (de) * 2005-03-11 2010-07-15 Oncotherapy Science Inc Verfahren zur schädigung von zellen mit effektorfunktionen von anti-gfra1-antikörpern
CN101273145A (zh) * 2005-07-28 2008-09-24 肿瘤疗法科学股份有限公司 癌症相关基因rasgef1a
CN101278060B (zh) 2005-07-29 2011-09-07 肿瘤疗法科学股份有限公司 作为乳腺癌标志的基因galnt6和针对基因galnt6的小干扰rna
JP2007037421A (ja) * 2005-08-01 2007-02-15 Osaka Univ 大腸癌リンパ節転移の有無を予測するための遺伝子セット
WO2007141595A2 (en) 2005-11-10 2007-12-13 Aurelium Biopharma Inc. Method of diagnosing breast cancer using protein markers
WO2007061770A2 (en) * 2005-11-17 2007-05-31 University Of Maryland Method and system for analysis of time-series molecular quantities
EP2295561A3 (en) * 2006-02-03 2011-06-29 Oriental Yeast Co., Ltd. Gene group applicable to cancer prognostication
JP5321780B2 (ja) 2006-02-10 2013-10-23 オンコセラピー・サイエンス株式会社 肺癌の治療方法
US20080108065A1 (en) * 2006-04-28 2008-05-08 Indra Poola Systems and diagnostic methods for breast cancer using mmp-1 markers
KR20090064378A (ko) 2006-08-10 2009-06-18 온코세라피 사이언스 가부시키가이샤 유방암 관련 유전자 및 폴리펩티드
EP3135773A1 (en) * 2006-09-27 2017-03-01 Sividon Diagnostics GmbH Methods for breast cancer prognosis
WO2008093427A1 (ja) * 2007-02-01 2008-08-07 Oriental Yeast Co., Ltd. 乳癌細胞の検出方法
US8105796B2 (en) * 2007-02-15 2012-01-31 Universita' Degli Studi Di Torino Regulation of expression of PI3Kβ protein in tumors
TW200908998A (en) * 2007-06-27 2009-03-01 Oncotherapy Science Inc Compositions and methods of treating cancer
RU2487886C2 (ru) * 2007-08-20 2013-07-20 Онкотерапи Сайенс, Инк. Пептид foxm1 и включающее его медицинское средство
PL2186889T3 (pl) 2007-08-20 2015-09-30 Oncotherapy Science Inc Peptyd CDCA1 i środek farmaceutyczny go zawierający
GB2467467C (en) * 2007-10-04 2013-03-20 A Star Agency For Science Technology And Res TAZ/WWTR1 for diagnosis and treatment of cancer
US8088715B2 (en) * 2007-11-13 2012-01-03 Ikonisys, Inc. Detection of circulating tumor cells in peripheral blood with an automated scanning fluorescence microscope
WO2009089548A2 (en) * 2008-01-11 2009-07-16 H. Lee Moffitt Cancer & Research Institute, Inc. Malignancy-risk signature from histologically normal breast tissue
WO2009116860A1 (en) * 2008-03-17 2009-09-24 Vereniging Het Nederlands Kanker Instituut Markers providing prognosis of metastasis among cancer patients
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Cdca1抗原決定位胜肽及含此胜肽的疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
US20100055705A1 (en) * 2008-08-29 2010-03-04 Wilson Gerald M Compositions and methods for diagnosing and treating cancer
TWI469791B (zh) 2009-02-18 2015-01-21 Oncotherapy Science Inc Foxm1胜肽以及含此胜肽之疫苗
KR101174369B1 (ko) 2009-05-01 2012-08-16 한국생명공학연구원 유방암 진단용 바이오마커 및 유방암 진단제
US20120195488A1 (en) * 2009-05-29 2012-08-02 University Of Utah Research Foundation Methods and Compositions Related to Cellular Assays
US20110217701A1 (en) * 2010-03-03 2011-09-08 Carter Scott L Prognostic Marker for Endometrial Carcinoma
AU2011239707A1 (en) * 2010-04-13 2012-11-08 The Trustees Of Columbia University In The City Of New York Biomarkers based on a multi-cancer invasion-associated mechanism
EP2426216A1 (en) * 2010-09-01 2012-03-07 Institut Gustave Roussy (IGR) Prognostic and/or predictive biomarkers and biological applications thereof
WO2012045905A2 (es) 2010-10-06 2012-04-12 Fundació Privada Institut De Recerca Biomèdica Método para el diagnóstico, pronóstico y tratamiento de la metástasis de cáncer de mama
WO2012056694A1 (ja) 2010-10-26 2012-05-03 国立大学法人山口大学 乳がん発症感受性の判定方法
WO2012066093A1 (en) * 2010-11-19 2012-05-24 Santaris Pharma A/S Compounds for the modulation of pdz-binding kinase (pbk) expression
AU2011351990A1 (en) * 2010-12-29 2013-07-18 Expression Pathology, Inc. Protein biomarkers of recurrent breast cancer
CN102312002A (zh) * 2011-09-20 2012-01-11 李艳 一种快速检测BRCA1基因mRNA表达量的试剂盒
EP2771464B1 (en) * 2011-10-27 2018-03-21 Yeda Research and Development Co. Ltd. Methods of treating cancer
SG2014012363A (en) 2011-10-28 2014-09-26 Oncotherapy Science Inc Topk peptides and vaccines including the same
EP2650682A1 (en) 2012-04-09 2013-10-16 Fundació Privada Institut de Recerca Biomèdica Method for the prognosis and treatment of cancer metastasis
RU2619739C2 (ru) * 2012-05-30 2017-05-17 Федеральное государственное бюджетное учреждение "Российский научный центр рентгенорадиологии" Министерства здравоохранения российской федерации (ФГБУ "РНЦРР" Минздрава России) Способ диагностики и прогноза при гиперпролиферативных заболеваниях молочной железы
US9687538B2 (en) 2012-07-10 2017-06-27 Oncotherapy Science, Inc. CDCA1 epitope peptides for Th1 cells and vaccines containing the same
WO2014041784A1 (en) 2012-09-11 2014-03-20 Oncotherapy Science, Inc. Ube2t peptides and vaccines containing the same
CA2896414C (en) * 2012-12-26 2023-06-20 Koninklijke Philips N.V. Assessment of cellular signaling pathway activity using linear combination(s) of target gene expressions
TWI658049B (zh) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 Kntc2胜肽及含此胜肽之疫苗
MX362041B (es) * 2013-10-09 2019-01-07 Fundacio Inst De Recerca Biomedica Irb Barcelona Método para el pronóstico y tratamiento de cáncer metastásico de los huesos originado de cáncer de mama.
JP2017512493A (ja) * 2014-03-14 2017-05-25 ブライアン ジェイ ツェルニキCZERNIECKI, Brian, J. 癌のcd4+tヘルパー1型応答の監視方法および免疫回復
CN113321704A (zh) 2014-08-04 2021-08-31 肿瘤疗法科学股份有限公司 Cdca1衍生的肽和含有它们的疫苗
US10311681B2 (en) 2015-08-19 2019-06-04 Mark A. Litman Electronic table game platform with secondary random event displays
US10380834B2 (en) 2015-07-22 2019-08-13 Mark A. Litman Replaceable flexible electronic table top with display function for gaming tables
AU2016335731B2 (en) 2015-10-08 2021-05-06 Oncotherapy Science, Inc. FOXM1-derived peptide, and vaccine including same
US11609427B2 (en) 2015-10-16 2023-03-21 Ostendo Technologies, Inc. Dual-mode augmented/virtual reality (AR/VR) near-eye wearable displays
US11106273B2 (en) * 2015-10-30 2021-08-31 Ostendo Technologies, Inc. System and methods for on-body gestural interfaces and projection displays
KR102541256B1 (ko) 2015-11-30 2023-06-12 (주)아모레퍼시픽 Lipa 억제를 통한 흑색종 예방 또는 치료제, 및 그 스크리닝 방법
KR102475128B1 (ko) 2015-11-30 2022-12-07 (주)아모레퍼시픽 Entpd4 억제를 통한 흑색종 예방 또는 치료제, 및 그 스크리닝 방법
US10345594B2 (en) 2015-12-18 2019-07-09 Ostendo Technologies, Inc. Systems and methods for augmented near-eye wearable displays
US10578882B2 (en) 2015-12-28 2020-03-03 Ostendo Technologies, Inc. Non-telecentric emissive micro-pixel array light modulators and methods of fabrication thereof
US10353203B2 (en) 2016-04-05 2019-07-16 Ostendo Technologies, Inc. Augmented/virtual reality near-eye displays with edge imaging lens comprising a plurality of display devices
US10453431B2 (en) 2016-04-28 2019-10-22 Ostendo Technologies, Inc. Integrated near-far light field display systems
US10522106B2 (en) 2016-05-05 2019-12-31 Ostendo Technologies, Inc. Methods and apparatus for active transparency modulation
PL3458610T3 (pl) 2016-05-25 2021-11-22 Inbiomotion S.L. Leczenie raka piersi w oparciu o status c-MAF
PT3466978T (pt) * 2016-06-03 2021-05-07 Univ Kyushu Nat Univ Corp Proteína de fusão para melhorar a expressão proteica de arnm alvo
CA3127820C (en) 2016-10-19 2022-03-01 The University Of British Columbia Process for leaching metal sulfides with reagents having thiocarbonyl functional groups
EP3548035A4 (en) 2016-11-30 2020-07-22 Case Western Reserve University COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
JP2020514323A (ja) 2017-02-06 2020-05-21 ケース ウエスタン リザーブ ユニバーシティ 短鎖デヒドロゲナーゼ活性を調節する組成物と方法
KR102091747B1 (ko) * 2017-11-15 2020-03-20 주식회사 프로탄바이오 유방암 진단용 바이오마커 및 이의 용도
BR112020010192A2 (pt) 2017-11-22 2020-10-13 Inbiomotion S.L. tratamento terapêutico de câncer de mama com base no status de c-maf
CN108441559B (zh) * 2018-02-27 2021-01-05 海门善准生物科技有限公司 一种免疫相关基因群作为标志物在制备评估高增殖性乳腺癌远处转移风险的产品中的应用
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
CN109234384A (zh) * 2018-10-31 2019-01-18 中国医学科学院阜外医院 Hmgcl作为诊断标志物和治疗靶点在致密化不全型心肌病的应用
CA3118585A1 (en) * 2018-11-04 2020-05-07 Pfs Genomics, Inc. Methods and genomic classifiers for prognosis of breast cancer and predicting benefit from adjuvant radiotherapy
PE20212246A1 (es) 2018-11-21 2021-11-24 Univ Case Western Reserve Composiciones y metodos para modular la actividad de deshidrogenasas de cadena corta
CN109811059B (zh) * 2019-03-31 2021-10-19 青岛泱深生物医药有限公司 生物标志物uggt1在宫颈疾病中的应用
WO2022056475A1 (en) * 2020-09-14 2022-03-17 Duke University Compositions and methods for diagnosing and treating a dystonia
MX2023003207A (es) 2020-09-18 2023-04-27 Jetti Resources Llc Extracto de metales base con un agente humectante y un reactivo de grupo funcional de tiocarbonilo.
CN113025720B (zh) * 2021-04-28 2022-12-27 深圳市人民医院 一种用于检测原发性乳腺弥漫性大b细胞淋巴瘤的标志物及其试剂盒和应用
CN113466447B (zh) * 2021-05-28 2024-03-08 天津市肿瘤医院(天津医科大学肿瘤医院) 诊断胰腺癌预后的肿瘤标志物bzw1及检测试剂盒
CN114931665B (zh) * 2021-12-14 2024-09-27 广州医科大学 六型胶原α2亚基在神经修复产品中的应用
CN114561358B (zh) * 2022-03-09 2023-10-03 广州源井生物科技有限公司 一种提高细胞慢病毒感染率的增强感染培养基及方法
CN114561470B (zh) * 2022-03-19 2024-03-01 新乡医学院 三阴性乳腺癌分子标志物及其应用
CN115616214A (zh) * 2022-09-20 2023-01-17 湖南中医药大学 Sox10抗体的应用、试剂盒
US12366923B2 (en) 2022-09-26 2025-07-22 Pison Technology, Inc. Systems and methods for gesture inference using ML model selection
US12366920B2 (en) 2022-09-26 2025-07-22 Pison Technology, Inc. Systems and methods for gesture inference using transformations
US12340627B2 (en) 2022-09-26 2025-06-24 Pison Technology, Inc. System and methods for gesture inference using computer vision
US12502110B2 (en) 2023-10-24 2025-12-23 Pison Technology, Inc. Systems and methods for determining physiological state based on surface biopotentials
CN118243927A (zh) * 2024-04-29 2024-06-25 东莞市石碣医院 eIF3b作为乳腺癌耐药检测靶点的应用
CN119007982A (zh) * 2024-07-26 2024-11-22 大连医科大学附属第二医院 基于肿瘤浸润边缘e-tls预测非小细胞肺癌预后的方法和设备
CN119955854B (zh) * 2025-01-20 2025-09-09 中国人民解放军军事科学院军事医学研究院 一种侏儒症小鼠模型的构建方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
JP2001501447A (ja) * 1996-01-11 2001-02-06 コリクサ コーポレイション 乳癌の処置および診断のための組成物および方法
US5968747A (en) * 1997-12-12 1999-10-19 Incyte Pharmaceuticals, Inc. Ubiquitin-like conjugating protein
AU2002218770A1 (en) * 2000-07-11 2002-01-21 Corixa Corporaton Compositions and methods for the therapy and diagnosis of lung cancer
JP2004510442A (ja) * 2000-10-03 2004-04-08 グラクソ グループ リミテッド 腫瘍マーカーおよび使用方法
US20030157544A1 (en) * 2000-10-30 2003-08-21 Eos Biotechnology, Inc. Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
US20030104418A1 (en) * 2001-04-27 2003-06-05 Chao Zhang Diagnostic markers for breast cancer
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
EP1546410A2 (en) 2002-09-30 2005-06-29 Oncotherapy Science, Inc. Method for diagnosing testicular seminomas
EP1856278A2 (en) 2005-02-10 2007-11-21 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
KR20090064378A (ko) 2006-08-10 2009-06-18 온코세라피 사이언스 가부시키가이샤 유방암 관련 유전자 및 폴리펩티드
TW200908998A (en) * 2007-06-27 2009-03-01 Oncotherapy Science Inc Compositions and methods of treating cancer

Similar Documents

Publication Publication Date Title
JP2007506426A5 (enExample)
JP6430560B2 (ja) 前立腺癌マーカーとしてのホスホジエステラーゼ4d7
JP2006500949A5 (enExample)
JP2009502115A5 (enExample)
JP2006500948A5 (enExample)
EP2691538A1 (en) Markers associated with cyclin-dependent kinase inhibitors
CA2676179A1 (en) Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors
KR20110014979A (ko) 항바이러스 요법
KR20160061424A (ko) 유방암으로부터 기원하는 골의 전이성 암의 예후 및 치료 방법
JP2010535014A5 (enExample)
JP2012501164A5 (enExample)
JP2005537027A5 (enExample)
CN113195739A (zh) 用于对骨髓干细胞疗法的响应的预测的方法
JP2005537007A5 (enExample)
JP2008512984A5 (enExample)
WO2010015618A1 (en) Method for determining a predisposition to basal cell carcinoma and for screening treatments thereof
JP2018504909A5 (enExample)
JP2010502192A5 (enExample)
JP7177439B2 (ja) 炎症促進因子発現抑制剤、その有効成分のスクリーニング方法、該方法に有用な発現カセット、診断薬、及び診断方法
US20110236396A1 (en) Methods and compositions for diagnosing and treating a colorectal adenocarcinoma
JP2006503575A5 (enExample)
JP2009505633A5 (enExample)
CN110055332A (zh) 与甲状腺癌相关的标志物及其应用
JP2004187620A (ja) 腎疾患の疾患マーカーおよびその利用
JP2010014689A (ja) プロテオミクス解析を用いたメラノーママーカーの同定